-
DISEASE BURDEN AND HEALTHCARE UTILIZATION AFTER DIAGNOSIS OF NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS (NF1-PN) IN SWEDISH PEDIATRIC PATIENTS: A REGISTRY-BASED STUDY
Aug 11, 2026, 17:16 PM -
COST-UTILITY OF SOX WITH BEVACIZUMAB IN COLORECTAL CANCER AMONG INDIAN POPULATION
Aug 11, 2026, 17:16 PM -
WHAT DRIVES POSITIVE NICE HEALTHTECH DECISIONS? A REVIEW OF ECONOMIC EVALUATION EVIDENCE FROM RECENT APPRAISALS
Aug 11, 2026, 17:16 PM -
EVOLUTION OF SOCIAL MEDIA CONVERSATIONS ABOUT OBESITY AND GLP-1 TREATMENTS IN FRANCE BETWEEN 2016 AND 2026 : A SOCIAL LISTENING STUDY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS AND UNCERTAINTY ANALYSIS OF EBOLA VACCINATION STRATEGIES IN CHILDREN AND ADOLESCENTS
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVALUATION OF SGLT2 INHIBITORS IN HEART FAILURE WITH REDUCED EJECTION FRACTION: A RETROSPECTIVE COHORT STUDY
Aug 11, 2026, 17:16 PM -
IS EQ-5D-5L FULL HEALTH UNIVERSAL? EVIDENCE FROM THE EQ-DAPHNIE DATASET
Aug 11, 2026, 17:16 PM -
PRIOR EXPERIENCE DOES NOT MODIFY THE MOTIVATIONAL OR INHIBITORY COMPONENTS OF PREDISPOSITION TO TELEMEDICINE ADOPTION: MULTIGROUP EVIDENCE FOR BUILDING TECHNOLOGICAL READINESS IN THE BRAZILIAN AMAZON
Aug 11, 2026, 17:16 PM -
MEETING REGULATORY TARGETS, MISSING REIMBURSEMENT: EVIDENCE OF A SYSTEMATIC ENDPOINT MISMATCH IN PULMONARY ARTERIAL HYPERTENSION
Aug 11, 2026, 17:16 PM -
THRESHOLD SENSITIVITY ANALYSIS OF ADJUVANT TRASTUZUMAB IN HER2-POSITIVE EARLY BREAST CANCER IN INDIA
Aug 11, 2026, 17:16 PM -
QUANTIFYING PATIENT PREFERENCES FOR TYPE 2 DIABETES TREATMENTS AMONGST INDIVIDUALS IN CHINA: A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
POTENTIAL IMPACT OF U.S MFN PRICING ON EX-US PRODUCT LAUNCH AND WITHDRAWAL STRATEGIES
Aug 11, 2026, 17:16 PM -
ADDRESSING EQ-5D CEILING EFFECTS THROUGH A DISEASE-SPECIFIC SYMPTOM THRESHOLD: A PATIENT-LEVEL ANALYSIS INFORMING THE NICE APPRAISAL OF DUPILUMAB IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Aug 11, 2026, 17:16 PM -
ANALYZING THE ASSOCIATION OF EMERGENCY CARE USE AND SHARED DECISION-MAKING: EVIDENCE FROM MEPS 2002-2023
Aug 11, 2026, 17:16 PM -
THE INVISIBLE BURDEN OF GLIOBLASTOMA - COMBINING LITERATURE REVIEW WITH PATIENT AND CAREGIVER QUALITATIVE INSIGHTS
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF AN INTEGRATED FRAMEWORK AND AI-ASSISTED PLATFORM FOR COMPLIANT AND SCALABLE REAL-WORLD EVIDENCE GENERATION USING REGIONAL HEALTHCARE DATA IN CHINA
Aug 11, 2026, 17:16 PM -
FROM LIMITED ACCESS TO RISING EXPENDITURE: TRENDS IN IMPORTED MEDICINES DISPENSED THROUGH PUBLIC OUTPATIENT PHARMACIES IN GREECE, 2020-2025
Aug 11, 2026, 17:16 PM -
FROM DETECTION TO ACTION: USING ECOA MONITORING SIGNALS TO DRIVE TARGETED INTERVENTION
Aug 11, 2026, 17:16 PM -
DEAL OR NO DEAL: THE EVOLVING USE OF COMMERCIAL ACCESS MECHANISMS IN NICE TECHNOLOGY APPRAISALS
Aug 11, 2026, 17:16 PM -
ADAPTING RAPID REVIEW METHODS FOR HEOR DECISION-MAKING: A FIT-FOR-PURPOSE FRAMEWORK FOR EFFICIENT EVIDENCE SYNTHESIS
Aug 11, 2026, 17:16 PM
